TY - JOUR
T1 - Septic Cardiomyopathy
T2 - From Pathophysiology to the Clinical Setting
AU - Carbone, Federico
AU - Liberale, Luca
AU - Preda, Alberto
AU - Schindler, Thomas Hellmut
AU - Montecucco, Fabrizio
N1 - Funding Information:
This research was funded by a grant from the Rete Cardiologica of Italian Ministry of Health (#2754291) to Federico Carbone. The research was funded by a grant from the Internal Medicine Department of the University of Genoa to Federico Carbone.
Publisher Copyright:
© 2022 by the authors.
PY - 2022/9
Y1 - 2022/9
N2 - The onset of cardiomyopathy is a common feature in sepsis, with relevant effects on its pathophysiology and clinical care. Septic cardiomyopathy is characterized by reduced left ventricular (LV) contractility eventually associated with LV dilatation with or without right ventricle failure. Unfortunately, such a wide range of ultrasonographic findings does not reflect a deep comprehension of sepsis-induced cardiomyopathy, but rather a lack of consensus about its definition. Several echocardiographic parameters intrinsically depend on loading conditions (both preload and afterload) so that it may be challenging to discriminate which is primitive and which is induced by hemodynamic perturbances. Here, we explore the state of the art in sepsis-related cardiomyopathy. We focus on the shortcomings in its definition and point out how cardiac performance dynamically changes in response to different hemodynamic clusters. A special attention is also given to update the knowledge about molecular mechanisms leading to myocardial dysfunction and that recall those of myocardial hibernation. Ultimately, the aim of this review is to highlight the unsolved issue in the field of sepsis-induced cardiomyopathy as their implementation would lead to improve risk stratification and clinical care.
AB - The onset of cardiomyopathy is a common feature in sepsis, with relevant effects on its pathophysiology and clinical care. Septic cardiomyopathy is characterized by reduced left ventricular (LV) contractility eventually associated with LV dilatation with or without right ventricle failure. Unfortunately, such a wide range of ultrasonographic findings does not reflect a deep comprehension of sepsis-induced cardiomyopathy, but rather a lack of consensus about its definition. Several echocardiographic parameters intrinsically depend on loading conditions (both preload and afterload) so that it may be challenging to discriminate which is primitive and which is induced by hemodynamic perturbances. Here, we explore the state of the art in sepsis-related cardiomyopathy. We focus on the shortcomings in its definition and point out how cardiac performance dynamically changes in response to different hemodynamic clusters. A special attention is also given to update the knowledge about molecular mechanisms leading to myocardial dysfunction and that recall those of myocardial hibernation. Ultimately, the aim of this review is to highlight the unsolved issue in the field of sepsis-induced cardiomyopathy as their implementation would lead to improve risk stratification and clinical care.
KW - cardiomyopathy
KW - inflammation
KW - sepsis
KW - septic shock
UR - http://www.scopus.com/inward/record.url?scp=85138347644&partnerID=8YFLogxK
U2 - 10.3390/cells11182833
DO - 10.3390/cells11182833
M3 - Review article
C2 - 36139408
AN - SCOPUS:85138347644
SN - 2073-4409
VL - 11
JO - Cells
JF - Cells
IS - 18
M1 - 2833
ER -